- Medicare drug price rule may target under-the-skin Keytruda and Opdivo<figure><div><img src="https://imgproxy.divecdn.com/yNFj1iOXXiGXHrvNzMITrI7Zf52PfwK1rovRc0StZW8/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xMDQ3NTA1MDAwLmpwZ…BioPharma Dive · 1mo ago↗ source
- Six leaders working on LGBTQ+ inclusion in biopharmaIt’s been a tough 18 months for the LGBTQ+ community. The American Civil Liberties Union tracked 530 anti-LGBTQ bills across dozens of states this year. Nearly 40% of US workers say ...Endpoints · 1mo ago↗ source
- Lilly scores early positive data for new JAK drug<figure><div><img src="https://imgproxy.divecdn.com/BektaG64-yby8Y5l-Eb4j51Y6ClyucnWH1-PThZhx4E/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDE0NDc0NzEzLmpwZ…